Breakthrough Heart Support Technologies

Abiomed's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum, from the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons. 

Impella® Platform

Percutaneous, Catheter Based

Impella.2.5

Impella 2.5

In June 2008, the Impella 2.5 received FDA 510(k) clearance for partial circulatory support for periods up to 6 hours.

impella-cp

Impella CP

In September 2012, the Impella CP received FDA 510(k) clearance circulatory support for periods up to 6 hours.

Impella.5.0

Impella 5.0

In April 2009, the Impella 5.0 received FDA 510(k) clearance circulatory support for periods up to 6 hours.

Impella.LD

Impella LD

In April 2009, the Impella LD received FDA 510(k) clearance circulatory support for periods up to 6 hours.

impella-controller

Automated Impella Controller

In July 2010, the Impella® Controller received FDA 510(k) clearance for intended use by trained healthcare professionals in healthcare facilities and medical transport (ie, ambulance, helicopter, or fixed-wing aircraft) environments.


AB Platform

Ambulatory, Biventricular

portable-driver

AB Portable Driver

In March 2009, the AB Portable received pre-market approval (PMA) for intra-facility patient transport, patient mobility for participation in physical and rehabilitation therapies, independent ambulation by the patient, and inter-hospital transport via aircraft or ambulance.

ab-vent

AB5000 Ventricle

In April 2004, the AB5000 ventricle received pre-market approval (PMA) to provide temporary support for one or both sides of the heart, giving the patient's heart the opportunity to rest and potentially recover

« back to top